101 related articles for article (PubMed ID: 27032314)
1. Effects of the dimeric PSD-95 inhibitor UCCB01-144 in mouse models of pain, cognition and motor function.
Andreasen JT; Nasser A; Caballero-Puntiverio M; Sahlholt M; Bach A; Gynther M; Strømgaard K; Pickering DS
Eur J Pharmacol; 2016 Jun; 780():166-73. PubMed ID: 27032314
[TBL] [Abstract][Full Text] [Related]
2. UCCB01-125, a dimeric inhibitor of PSD-95, reduces inflammatory pain without disrupting cognitive or motor performance: comparison with the NMDA receptor antagonist MK-801.
Andreasen JT; Bach A; Gynther M; Nasser A; Mogensen J; Strømgaard K; Pickering DS
Neuropharmacology; 2013 Apr; 67():193-200. PubMed ID: 23178182
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo effects of a novel dimeric inhibitor of PSD-95 on excitotoxicity and functional recovery after experimental traumatic brain injury.
Sommer JB; Bach A; Malá H; Strømgaard K; Mogensen J; Pickering DS
Eur J Neurosci; 2017 Jan; 45(2):238-248. PubMed ID: 27859797
[TBL] [Abstract][Full Text] [Related]
4. Analgesic effects and possible mechanisms of iridoid glycosides from Lamiophlomis rotata (Benth.) Kudo in rats with spared nerve injury.
Zheng Y; Yin X; Huo F; Xiong H; Mei Z
J Ethnopharmacol; 2015 Sep; 173():204-11. PubMed ID: 26160748
[TBL] [Abstract][Full Text] [Related]
5. Selectivity, efficacy and toxicity studies of UCCB01-144, a dimeric neuroprotective PSD-95 inhibitor.
Bach A; Clausen BH; Kristensen LK; Andersen MG; Ellman DG; Hansen PBL; Hasseldam H; Heitz M; Özcelik D; Tuck EJ; Kopanitsa MV; Grant SGN; Lykke-Hartmann K; Johansen FF; Lambertsen KL; Strømgaard K
Neuropharmacology; 2019 May; 150():100-111. PubMed ID: 30836092
[TBL] [Abstract][Full Text] [Related]
6. PCC-0105002, a novel small molecule inhibitor of PSD95-nNOS protein-protein interactions, attenuates neuropathic pain and corrects motor disorder associated with neuropathic pain model.
Sun Z; Meng P; Su C; Ji S; Gao Y; Wang H; Tian J; Li C
Toxicol Appl Pharmacol; 2021 Oct; 429():115698. PubMed ID: 34428447
[TBL] [Abstract][Full Text] [Related]
7. D-Aspartate drinking solution alleviates pain and cognitive impairment in neuropathic mice.
Palazzo E; Luongo L; Guida F; Marabese I; Romano R; Iannotta M; Rossi F; D'Aniello A; Stella L; Marmo F; Usiello A; de Bartolomeis A; Maione S; de Novellis V
Amino Acids; 2016 Jul; 48(7):1553-67. PubMed ID: 27115160
[TBL] [Abstract][Full Text] [Related]
8. Effects of the dimeric PSD-95 inhibitor UCCB01-144 on functional recovery after fimbria-fornix transection in rats.
Sommer JB; Bach A; Malá H; Strømgaard K; Mogensen J; Pickering DS
Pharmacol Biochem Behav; 2017 Oct; 161():62-67. PubMed ID: 28943199
[TBL] [Abstract][Full Text] [Related]
9. A pain killer without analgesic tolerance designed by co-targeting PSD-95-nNOS interaction and α2-containning GABA
Li J; Zhang L; Xu C; Shen YY; Lin YH; Zhang Y; Wu HY; Chang L; Zhang YD; Chen R; Zhang ZP; Luo CX; Li F; Zhu DY
Theranostics; 2021; 11(12):5970-5985. PubMed ID: 33897893
[TBL] [Abstract][Full Text] [Related]
10. Effects of Dimeric PSD-95 Inhibition on Excitotoxic Cell Death and Outcome After Controlled Cortical Impact in Rats.
Sommer JB; Bach A; Malá H; Gynther M; Bjerre AS; Gram MG; Marschner L; Strømgaard K; Mogensen J; Pickering DS
Neurochem Res; 2017 Dec; 42(12):3401-3413. PubMed ID: 28828633
[TBL] [Abstract][Full Text] [Related]
11. Trifluoro-icaritin alleviates mechanical hypersensitivity and improves motor coordination and balance in rats with spared nerve injury-induced neuropathic pain.
Jia D; Sun Y; Liu G; Xue M; Huang Z; Huang C
Neurosci Lett; 2021 Sep; 761():136125. PubMed ID: 34302890
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase 2 expression in the spared nerve injury model of neuropathic pain.
Broom DC; Samad TA; Kohno T; Tegeder I; Geisslinger G; Woolf CJ
Neuroscience; 2004; 124(4):891-900. PubMed ID: 15026129
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory pain may induce cognitive impairment through an interlukin-6-dependent and postsynaptic density-95-associated mechanism.
Yang L; Xin X; Zhang J; Zhang L; Dong Y; Zhang Y; Mao J; Xie Z
Anesth Analg; 2014 Aug; 119(2):471-480. PubMed ID: 24878682
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal injection of the peptide myr-NR2B9c attenuates bone cancer pain via perturbing N-methyl-D-aspartate receptor-PSD-95 protein interactions in mice.
Liu Y; Cui X; Sun YE; Yang X; Ni K; Zhou Y; Ma Z; Gu X
Anesth Analg; 2014 Jun; 118(6):1345-54. PubMed ID: 24842180
[TBL] [Abstract][Full Text] [Related]
15. PSD-95 uncoupling from NMDA receptors by Tat- N-dimer ameliorates neuronal depolarization in cortical spreading depression.
Kucharz K; Søndergaard Rasmussen I; Bach A; Strømgaard K; Lauritzen M
J Cereb Blood Flow Metab; 2017 May; 37(5):1820-1828. PubMed ID: 27107027
[TBL] [Abstract][Full Text] [Related]
16. Antihyperalgesic effects of myrsinoic acid B in pain-like behavior induced by inflammatory and neuropathic pain models in mice.
Antonialli Cde S; da Silva GF; Rocha LW; Monteiro ER; de Souza MM; Malheiros A; Yunes RA; Quintão NL
Anesth Analg; 2012 Aug; 115(2):461-9. PubMed ID: 22523418
[TBL] [Abstract][Full Text] [Related]
17. (+)-Borneol alleviates mechanical hyperalgesia in models of chronic inflammatory and neuropathic pain in mice.
Jiang J; Shen YY; Li J; Lin YH; Luo CX; Zhu DY
Eur J Pharmacol; 2015 Jun; 757():53-8. PubMed ID: 25835611
[TBL] [Abstract][Full Text] [Related]
18. Delayed sympathetic dependence in the spared nerve injury (SNI) model of neuropathic pain.
Pertin M; Allchorne AJ; Beggah AT; Woolf CJ; Decosterd I
Mol Pain; 2007 Jul; 3():21. PubMed ID: 17672895
[TBL] [Abstract][Full Text] [Related]
19. Analgesic effect of total flavonoids from Sanguis draxonis on spared nerve injury rat model of neuropathic pain.
Chen FF; Huo FQ; Xiong H; Wan Q; Zheng YN; Du WJ; Mei ZN
Phytomedicine; 2015 Nov; 22(12):1125-32. PubMed ID: 26547536
[TBL] [Abstract][Full Text] [Related]
20. A back translation of pregabalin and carbamazepine against evoked and non-evoked endpoints in the rat spared nerve injury model of neuropathic pain.
Lau W; Dykstra C; Thevarkunnel S; Silenieks LB; de Lannoy IA; Lee DK; Higgins GA
Neuropharmacology; 2013 Oct; 73():204-15. PubMed ID: 23747575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
